1.

Porphyromonas gingivalis triggers the shedding of inflammatory endothelial microvesicles that act as autocrine effectors of endothelial dysfunction.

Bugueno IM, Zobairi El-Ghazouani F, Batool F, El Itawi H, Anglès-Cano E, Benkirane-Jessel N, Toti F, Huck O.

Sci Rep. 2020 Feb 4;10(1):1778. doi: 10.1038/s41598-020-58374-z.

2.

Surface characterization and bonding properties of milled polyetheretherketone dental posts.

Benli M, Eker Gümüş B, Kahraman Y, Huck O, Özcan M.

Odontology. 2020 Jan 21. doi: 10.1007/s10266-020-00484-1. [Epub ahead of print]

PMID:
31965408
3.

Orofacial manifestations and dental management of systemic lupus erythematosus: A review.

Benli M, Batool F, Stutz C, Petit C, Jung S, Huck O.

Oral Dis. 2019 Dec 30. doi: 10.1111/odi.13271. [Epub ahead of print] Review.

PMID:
31886584
4.

IL-36γ is a pivotal inflammatory player in periodontitis-associated bone loss.

Cloitre A, Halgand B, Sourice S, Caillon J, Huck O, Bugueno IM, Batool F, Guicheux J, Geoffroy V, Lesclous P.

Sci Rep. 2019 Dec 17;9(1):19257. doi: 10.1038/s41598-019-55595-9.

5.

Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction.

Huck O, Mulhall H, Rubin G, Kizelnik Z, Iyer R, Perpich JD, Haque N, Cani PD, de Vos WM, Amar S.

J Clin Periodontol. 2020 Feb;47(2):202-212. doi: 10.1111/jcpe.13214. Epub 2019 Dec 2.

PMID:
31674689
6.

Surface roughness and wear behavior of occlusal splint materials made of contemporary and high-performance polymers.

Benli M, Eker Gümüş B, Kahraman Y, Gökçen-Rohlig B, Evlioğlu G, Huck O, Özcan M.

Odontology. 2020 Apr;108(2):240-250. doi: 10.1007/s10266-019-00463-1. Epub 2019 Oct 14.

PMID:
31612354
7.

Experimental periodontitis in Msx2 mutant mice induces alveolar bone necrosis.

Korah L, Amri N, Bugueno IM, Hotton D, Tenenbaum H, Huck O, Berdal A, Davideau JL.

J Periodontol. 2019 Sep 30. doi: 10.1002/JPER.16-0435. [Epub ahead of print]

PMID:
31566253
8.

Identification of a Kavain Analog with Efficient Anti-inflammatory Effects.

Huck O, Han X, Mulhall H, Gumenchuk I, Cai B, Panek J, Iyer R, Amar S.

Sci Rep. 2019 Sep 10;9(1):12940. doi: 10.1038/s41598-019-49383-8.

9.

Application of Chitosan in Bone and Dental Engineering.

Aguilar A, Zein N, Harmouch E, Hafdi B, Bornert F, Offner D, Clauss F, Fioretti F, Huck O, Benkirane-Jessel N, Hua G.

Molecules. 2019 Aug 19;24(16). pii: E3009. doi: 10.3390/molecules24163009. Review.

10.

In-situ forming implants loaded with chlorhexidine and ibuprofen for periodontal treatment: Proof of concept study in vivo.

Batool F, Agossa K, Lizambard M, Petit C, Bugueno IM, Delcourt-Debruyne E, Benkirane-Jessel N, Tenenbaum H, Siepmann J, Siepmann F, Huck O.

Int J Pharm. 2019 Oct 5;569:118564. doi: 10.1016/j.ijpharm.2019.118564. Epub 2019 Jul 25.

PMID:
31352049
11.

Inflammatory Mediators in Periodontal Pathogenesis.

Huck O, Buduneli N, Bravo D.

Mediators Inflamm. 2019 Jun 18;2019:2610184. doi: 10.1155/2019/2610184. eCollection 2019. No abstract available.

12.

Impact of tooth-related factors on photodynamic therapy effectiveness during active periodontal therapy: A 6-months split-mouth randomized clinical trial.

Harmouche L, Courval A, Mathieu A, Petit C, Huck O, Severac F, Davideau JL.

Photodiagnosis Photodyn Ther. 2019 Sep;27:167-172. doi: 10.1016/j.pdpdt.2019.05.022. Epub 2019 May 19.

PMID:
31116996
13.

Periodontal condition of patients with Thalassemia Major: A systematic review and meta-analysis.

Akcalı A, Yıldız MS, Akcalı Z, Huck O, Friedmann A.

Arch Oral Biol. 2019 Jun;102:113-121. doi: 10.1016/j.archoralbio.2019.04.004. Epub 2019 Apr 9.

PMID:
30999065
14.

Contribution of Statins towards Periodontal Treatment: A Review.

Petit C, Batool F, Bugueno IM, Schwinté P, Benkirane-Jessel N, Huck O.

Mediators Inflamm. 2019 Feb 27;2019:6367402. doi: 10.1155/2019/6367402. eCollection 2019. Review.

15.

No evidence to support benefit of 14-day courses of amoxicillin-plus-metronidazole as adjunct to non-surgical periodontal treatment at three months.

Martín-Cabezas R, Huck O.

Evid Based Dent. 2019 Mar;20(1):16-17. doi: 10.1038/s41432-019-0013-x.

PMID:
30903121
16.

Risk factors associated with long-term outcomes after active and supporting periodontal treatments: impact of various compliance definitions on tooth loss.

Petit C, Schmeltz S, Burgy A, Tenenbaum H, Huck O, Davideau JL.

Clin Oral Investig. 2019 Nov;23(11):4123-4131. doi: 10.1007/s00784-019-02851-x. Epub 2019 Feb 23.

PMID:
30798409
17.

Porphyromonas gingivalis bypasses epithelial barrier and modulates fibroblastic inflammatory response in an in vitro 3D spheroid model.

Bugueno IM, Batool F, Keller L, Kuchler-Bopp S, Benkirane-Jessel N, Huck O.

Sci Rep. 2018 Oct 8;8(1):14914. doi: 10.1038/s41598-018-33267-4.

18.

Kavain Reduces Porphyromonas gingivalis-Induced Adipocyte Inflammation: Role of PGC-1α Signaling.

Singh SP, Huck O, Abraham NG, Amar S.

J Immunol. 2018 Sep 1;201(5):1491-1499. doi: 10.4049/jimmunol.1800321. Epub 2018 Jul 23.

19.

Management of localized aggressive periodontitis: A 30-year follow-up.

Petit C, Huck O, Amar S, Tenenbaum H.

Quintessence Int. 2018;49(8):615-624. doi: 10.3290/j.qi.a40660.

PMID:
29930995
20.

Reduction of Articular and Systemic Inflammation by Kava-241 in a Porphyromonas gingivalis-Induced Arthritis Murine Model.

Huck O, You J, Han X, Cai B, Panek J, Amar S.

Infect Immun. 2018 Aug 22;86(9). pii: e00356-18. doi: 10.1128/IAI.00356-18. Print 2018 Sep.

Supplemental Content

Loading ...
Support Center